Targeting acid ceramidase inhibits YAP/TAZ signaling to reduce fibrosis in mice

Role of YAP/TAZ in mechanotransduction

Dupont, S., Morsut, L., Aragona, M., Enzo, E., Giulitti, S., Cordenonsi, M., Zanconato, F., Le Digabel, J., Forcato, M., Bicciato, S., et al. (2011) · Nature · doi:10.1038/nature10137 · Cited by 5,979

Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control

Zhao, B., Wei, X., Li, W., Udan, R. S., Yang, Q., Kim, J., Xie, J., Ikenoue, T., Yu, J., Li, L., et al. (2007) · Genes & Development · doi:10.1101/gad.1602907 · Cited by 3,092

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

Angulo, P., Kleiner, D. E., Dam-Larsen, S., Adams, L. A., Bjornsson, E. S., Charatcharoenwitthaya, P., Mills, P. R., Keach, J. C., Lafferty, H. D., Stahler, A., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.043 · Cited by 2,987

Fibrotic disease and the TH1/TH2 paradigm

Wynn, T. A. (2004) · Nature Reviews Immunology · doi:10.1038/nri1412 · Cited by 1,765

Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling

Yu, F.-X., Zhao, B., Panupinthu, N., Jewell, J. L., Lian, I., Wang, L. H., Zhao, J., Yuan, H., Tumaneng, K., Li, H., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.037 · Cited by 1,628

Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology

Mederacke, I., Hsu, C. C., Troeger, J. S., Huebener, P., Mu, X., Dapito, D. H., Pradere, J.-P., & Schwabe, R. F. (2013) · Nature Communications · doi:10.1038/ncomms3823 · Cited by 1,443

A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF β-TRCP

Zhao, B., Li, L., Tumaneng, K., Wang, C.-Y., & Guan, K.-L. (2010) · Genes & Development · doi:10.1101/gad.1843810 · Cited by 1,418

YAP1 increases organ size and expands undifferentiated progenitor cells

Camargo, F. D., Gokhale, S., Johnnidis, J. B., Fu, D., Bell, G. W., Jaenisch, R., & Brummelkamp, T. R. (2007) · Current Biology · doi:10.1016/j.cub.2007.10.039 · Cited by 1,252

The emerging roles of YAP and TAZ in cancer

Moroishi, T., Hansen, C. G., & Guan, K. (2015) · Nature reviews. Cancer · doi:10.1038/nrc3876 · Cited by 1,181

Yap1 acts downstream of α-catenin to control epidermal proliferation

Schlegelmilch, K., Mohseni, M., Kirak, O., Pruszak, J., Rodriguez, J. R., Zhou, D., Kreger, B. T., Vasioukhin, V., Avruch, J., Brummelkamp, T. R., et al. (2011) · Cell · doi:10.1016/j.cell.2011.02.031 · Cited by 1,036

Mst1 and Mst2 Maintain Hepatocyte Quiescence and Suppress Hepatocellular Carcinoma Development through Inactivation of the Yap1 Oncogene

Zhou, D., Conrad, C. H., Xia, F., Park, J.-S., Payer, B., Yin, Y., Lauwers, G. Y., Thasler, W. E., Lee, J. T., Avruch, J., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.09.026 · Cited by 937

The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment

Johnson, R. L., & Halder, G. A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4161 · Cited by 920

Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis

Liu, F., Lagares, D., Choi, K. M., Stopfer, L., Marinković, A., Vrbanac, V., Probst, C. K., Hiemer, S. E., Sisson, T. H., Horowitz, J. C., et al. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00300.2014 · Cited by 874

Targeting of αv integrin identifies a core molecular pathway that regulates fibrosis in several organs

Henderson, N. C., Arnold, T. D., Katamura, Y., Giacomini, M. M., Rodriguez, J. D., McCarty, J. H., Pellicoro, A., Raschperger, E., Betsholtz, C., Ruminski, P. G., et al. (2013) · Nature Medicine · doi:10.1038/nm.3282 · Cited by 866

Hepatic lipocytes: the principal collagen-producing cells of normal rat liver.

Friedman, S. L., Roll, F. J., Boyles, J., & Bissell, D. M. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.24.8681 · Cited by 859

Feedback amplification of fibrosis through matrix stiffening and COX-2 suppression

Liu, F., Mih, J. D., Shea, B. S., Kho, A. T., Sharif, A. S., Tager, A. M., & Tschumperlin, D. J. (2010) · The Journal of Cell Biology · doi:10.1083/jcb.201004082 · Cited by 828

Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver

Lu, L., Li, Y., Kim, S. M., Bossuyt, W., Liu, P., Qiu, Q., Wang, Y., Halder, G. A., Finegold, M. J., Lee, J., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911427107 · Cited by 721

Increased stiffness of the rat liver precedes matrix deposition: implications for fibrosis

Georges, P. C., Hui, J.-J., Gombos, Z., McCormick, M. E., Wang, A. Y., Uemura, M., Mick, R., Janmey, P. A., Furth, E. E., & Wells, R. G. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00032.2007 · Cited by 577

High-yield and high-purity isolation of hepatic stellate cells from normal and fibrotic mouse livers

Mederacke, I., Dapito, D. H., Affò, S., Uchinami, H., & Schwabe, R. F. (2015) · Nature Protocols · doi:10.1038/nprot.2015.017 · Cited by 548

Yes‐associated protein is an independent prognostic marker in hepatocellular carcinoma

Xu, M. Z., Yao, T., Lee, N. P. Y., Ng, I. O. L., Chan, Y., Zender, L., Lowe, S. W., Poon, R. T. P., & Luk, J. M. (2009) · Cancer · doi:10.1002/cncr.24495 · Cited by 528

An improved mouse model that rapidly develops fibrosis in non‐alcoholic steatohepatitis

Matsumoto, M., Hada, N., Sakamaki, Y., Uno, A., Shiga, T., Tanaka, C., Ito, T., Katsume, A., & Sudoh, M. (2013) · International Journal of Experimental Pathology · doi:10.1111/iep.12008 · Cited by 523

YAP/TAZ Are Mechanoregulators of TGF-β-Smad Signaling and Renal Fibrogenesis

Szeto, S. G., Narimatsu, M., Lu, M., He, X., Sidiqi, A. M., Tolosa, M. F., Chan, L., Freitas, K. D., Bialik, J. F., Majumder, S., et al. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015050499 · Cited by 478

The Compliance of Collagen Gels Regulates Transforming Growth Factor-β Induction of α-Smooth Muscle Actin in Fibroblasts

Arora, P. D., Narani, N., & McCulloch, C. A. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65334-5 · Cited by 474

Targeting a ceramide double bond improves insulin resistance and hepatic steatosis

Chaurasia, B., Tippetts, T. S., Mayoral, R., Liu, J., Li, Y., Wang, L., Wilkerson, J. L., Sweeney, C. R., Pereira, R. F., Sumida, D. H., et al. (2019) · Science · doi:10.1126/science.aav3722 · Cited by 463

Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease

Luukkonen, P. K., Zhou, Y., Sädevirta, S., Leivonen, M., Arola, J., Orešič, M., Hyötyläinen, T., & Yki-Järvinen, H. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.01.002 · Cited by 461

Hepatocyte TAZ/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis

Wang, X., Zheng, Z., Caviglia, J. M., Corey, K. E., Herfel, T. M., Cai, B., Masia, R., Chung, R. T., Lefkowitch, J. H., Schwabe, R. F., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.09.016 · Cited by 413

The Hippo pathway effector YAP controls mouse hepatic stellate cell activation

Mannaerts, I., Leite, S. B., Verhulst, S., Claerhout, S., Eysackers, N., Thoen, L. F. R., Hoorens, A., Reynaert, H., Halder, G., & van Grunsven, L. A. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.04.011 · Cited by 410

Preparation and incubation of precision-cut liver and intestinal slices for application in drug metabolism and toxicity studies

de Graaf, I. A. M., Olinga, P., de Jager, M. H., Merema, M. T., de Kanter, R., van de Kerkhof, E. G., & Groothuis, G. M. M. (2010) · Nature Protocols · doi:10.1038/nprot.2010.111 · Cited by 409

“Sternzellen” in the liver: Perisinusoidal cells with special reference to storage of vitamin A

Wake, K. (1971) · American Journal of Anatomy · doi:10.1002/aja.1001320404 · Cited by 388

Endothelin Induced Contractility of Stellate Cells From Normal and Cirrhotic Rat Liver: Implications for Regulation of Portal Pressure and Resistance

Rockey, D. C., & Weisiger, R. A. (1996) · Hepatology · doi:10.1002/hep.510240137 · Cited by 386

Targeted Induction of Ceramide Degradation Leads to Improved Systemic Metabolism and Reduced Hepatic Steatosis

Xia, J. Y., Holland, W. L., Kusminski, C. M., Sun, K., Sharma, A. X., Pearson, M. J., Sifuentes, A. J., McDonald, J. G., Gordillo, R., & Scherer, P. E. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.06.007 · Cited by 352

Transforming growth factor-β and substrate stiffness regulate portal fibroblast activation in culture

Li, Z., Dranoff, J. A., Chan, E. P., Uemura, M., Sévigny, J., & Wells, R. G. (2007) · Hepatology · doi:10.1002/hep.21792 · Cited by 338

Hippo Signaling Regulates Microprocessor and Links Cell-Density-Dependent miRNA Biogenesis to Cancer

Mori, M., Triboulet, R., Mohseni, M., Schlegelmilch, K., Shrestha, K., Camargo, F. D., & Gregory, R. I. (2014) · Cell · doi:10.1016/j.cell.2013.12.043 · Cited by 335

Induction of apoptotic cell death and prevention of tumor growth by ceramide analogues in metastatic human colon cancer.

Selzner, M., Bielawska, A. E., Morse, M. A., Rüdiger, H. A., Sindram, D., Hannun, Y. A., & Clavien, P. (2001) · PubMed · Cited by 334

Hepatic Gene Expression Profiles Differentiate Presymptomatic Patients With Mild Versus Severe Nonalcoholic Fatty Liver Disease

Moylan, C. A., Pang, H., Dellinger, A. E., Suzuki, A., Garrett, M. E., Guy, C. D., Murphy, S. K., Ashley‐Koch, A. E., Choi, S. S., Michelotti, G. A., et al. (2013) · Hepatology · doi:10.1002/hep.26661 · Cited by 319

Plasma Lipid Profiling Shows Similar Associations with Prediabetes and Type 2 Diabetes

Meikle, P. J., Wong, G., Barlow, C. K., Weir, J. M., Greeve, M. A., MacIntosh, G. L., Almasy, L. A., Comuzzie, A. G., Mahaney, M. C., Kowalczyk, A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074341 · Cited by 308

Nf2 /Merlin controls progenitor homeostasis and tumorigenesis in the liverPreprint

Benhamouche, S., Curto, M., Saotome, I., Gladden, A. B., Liu, C.-H., Giovannini, M., & McClatchey, A. I. (2010) · Genes & Development · doi:10.1101/gad.1938710 · Cited by 278

Bioinformatics strategies for lipidomics analysis: characterization of obesity related hepatic steatosis

Yetukuri, L., Katajamaa, M., Medina‐Gómez, G., Seppänen‐Laakso, T., Vidal‐Puig, A., & Orešič, M. (2007) · BMC Systems Biology · doi:10.1186/1752-0509-1-12 · Cited by 270

YAP and TAZ Regulate Skin Wound Healing

Lee, M.-J., Byun, M. R., Furutani‐Seiki, M., Hong, J., & Jung, H.-S. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.339 · Cited by 268

Single-Cell Analysis of the Liver Epithelium Reveals Dynamic Heterogeneity and an Essential Role for YAP in Homeostasis and Regeneration

Pepe-Mooney, B. J., Dill, M. T., Alemany, A., Ordovas-Montanes, J., Matsushita, Y., Rao, A., Sen, A., Miyazaki, M., Anakk, S., Dawson, P. A., et al. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2019.04.004 · Cited by 266

Modulation of transforming growth factor β response and signaling during transdifferentiation of rat hepatic stellate cells to myofibroblasts

Dooley, S., Delvoux, B., Lahme, B., Mangasser-Stephan, K., & Gressner, A. M. (2000) · Hepatology · doi:10.1053/he.2000.6126 · Cited by 229

Selective YAP/TAZ inhibition in fibroblasts via dopamine receptor D1 agonism reverses fibrosis

Haak, A. J., Kostallari, E., Sicard, D., Ligresti, G., Choi, K. M., Caporarello, N., Jones, D. L., Tan, Q., Meridew, J. A., Espinosa, A. M. D., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aau6296 · Cited by 227

PAK proteins and YAP-1 signalling downstream of integrin beta-1 in myofibroblasts promote liver fibrosis

Martin, K., Pritchett, J. P., Llewellyn, J., Mullan, A. F., Athwal, V. S., Dobie, R., Harvey, E., Zeef, L. A. H., Farrow, S. N., Streuli, C. H., et al. (2016) · Nature Communications · doi:10.1038/ncomms12502 · Cited by 223

Stiffening hydrogels for investigating the dynamics of hepatic stellate cell mechanotransduction during myofibroblast activation

Caliari, S. R., Perepelyuk, M., Cosgrove, B. D., Tsai, S. J., Lee, G. Y., Mauck, R. L., Wells, R. G., & Burdick, J. A. (2016) · Scientific Reports · doi:10.1038/srep21387 · Cited by 220

YAP, but Not RSPO-LGR4/5, Signaling in Biliary Epithelial Cells Promotes a Ductular Reaction in Response to Liver Injury

Planas-Paz, L., Sun, T., Pikiolek, M., Cochran, N. R., Bergling, S., Orsini, V., Yang, Z., Sigoillot, F., Jetzer, J., Syed, M., et al. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2019.04.005 · Cited by 216

Peritumoral activation of the Hippo pathway effectors YAP and TAZ suppresses liver cancer in mice

Moya, I. M., Castaldo, S. A., den Mooter, L. V., Soheily, S., Sansores-García, L., Jacobs, J., Mannaerts, I., Xie, J., Verboven, E., Hillen, H., et al. (2019) · Science · doi:10.1126/science.aaw9886 · Cited by 214

Ceramide as a Mediator of Non-Alcoholic Fatty Liver Disease and Associated Atherosclerosis

Kasumov, T., Li, L., Li, M., Gulshan, K., Kirwan, J. P., Liu, X., Previs, S. F., Willard, B. B., Smith, J. D., & McCullough, A. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126910 · Cited by 209

Physiological ranges of matrix rigidity modulate primary mouse hepatocyte function in part through hepatocyte nuclear factor 4 alpha

Desai, S. S., Tung, J. C., Zhou, V. X., Grenert, J. P., Malato, Y., Rezvani, M., Español‐Suñer, R., Willenbring, H., Weaver, V. M., & Chang, T. T. (2016) · Hepatology · doi:10.1002/hep.28450 · Cited by 185

Hepatic stellate cells and portal fibroblasts are the major cellular sources of collagens and lysyl oxidases in normal liver and early after injury

Perepelyuk, M., Terajima, M., Wang, A. Y., Georges, P. C., Janmey, P. A., Yamauchi, M., & Wells, R. G. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00222.2012 · Cited by 184

Circulating Sphingolipids, Insulin, HOMA-IR, and HOMA-B: The Strong Heart Family Study

Lemaître, R. N., Yu, C., Hoofnagle, A. N., Nair, H., Jensen, P. N., Fretts, A. M., Umans, J. G., Howard, B. V., Sitlani, C. M., Siscovick, D. S., et al. (2018) · Diabetes · doi:10.2337/db17-1449 · Cited by 184

Yap/Taz deletion in Gli(+) cell-derived myofibroblasts attenuates fibrosis

Liang, M., Yu, M., Xia, R., Song, K., Wang, J., Luo, J., Chen, G., & Cheng, J. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015121354 · Cited by 169

Hepatocyte Stress Increases Expression of Yes‐Associated Protein and Transcriptional Coactivator With PDZ‐Binding Motif in Hepatocytes to Promote Parenchymal Inflammation and Fibrosis

Mooring, M., Fowl, B. H., Lum, S. Z. C., Liu, Y., Yao, K., Softic, S., Kirchner, R., Bernstein, A., Singhi, A. D., Jay, D. G., et al. (2020) · Hepatology · doi:10.1002/hep.30928 · Cited by 162

Desmin and actin in the identification of Ito cells and in monitoring their evolution to myofibroblasts in experimental liver fibrosis

Ballardini, G., Fallani, M., Biagini, G., Bianchi, F. B., & Pisi, E. (1988) · Virchows Archiv B Cell Pathology Including Molecular Pathology · doi:10.1007/bf02890000 · Cited by 150

Exogenous cell-permeable C6 ceramide sensitizes multiple cancer cell lines to Doxorubicin-induced apoptosis by promoting AMPK activation and mTORC1 inhibition

Ji, C., Yang, B., Yang, Y.-L., He, S.-H., Miao, D.-S., He, L., & Bi, Z.-G. (2010) · Oncogene · doi:10.1038/onc.2010.379 · Cited by 149

Inhibition of ceramide de novo synthesis reduces liver lipid accumulation in rats with nonalcoholic fatty liver disease

Kurek, K., Ziembicka, D., Wiesiołek‐Kurek, P., Łukaszuk, B., Chabowski, A., Górski, J., & Żendzian‐Piotrowska, M. (2013) · Liver International · doi:10.1111/liv.12331 · Cited by 138

The ceramide analog, B13, induces apoptosis in prostate cancer cell lines and inhibits tumor growth in prostate cancer xenografts

Samsel, L., Zaidel, G., Drumgoole, H. M., Jelovac, D., Drachenberg, C., Rhee, J. G., Brodie, A. M. H., Bielawska, A. E., & Smyth, M. J. (2003) · The Prostate · doi:10.1002/pros.10350 · Cited by 128

Bcl‐2 overexpression prevents apoptosis induced by ceramidase inhibitors in malignant melanoma and HaCaT keratinocytes

Raisova, M., Goltz, G., Bektas, M., Bielawska, A. E., Riebeling, C., Hossini, A. M., Eberle, J., Hannun, Y. A., Orfanos, C. E., & Geilen, C. C. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02472-9 · Cited by 125

Precision-cut liver slices: a versatile tool to advance liver research

Palma, E., Doornebal, E. J., & Chokshi, S. (2019) · Hepatology International · doi:10.1007/s12072-018-9913-7 · Cited by 125

Sphingosine 1-phosphate (S1P)/S1P receptors are involved in human liver fibrosis by action on hepatic myofibroblasts motility

Li, C., Zheng, S., You, H., Liu, X., Lin, M., Yang, L., & Li, L. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.08.028 · Cited by 124

Expression and Clinical Significance of YAP, TAZ, and AREG in Hepatocellular Carcinoma

Han, S., Bai, E., Jin, G., He, C., Guo, X.-J., Wang, L., Li, M., Xia, Y., & Zhu, Q. (2014) · Journal of Immunology Research · doi:10.1155/2014/261365 · Cited by 124

Precision-cut liver slices: A tool to model the liver ex vivo

Olinga, P., & Schuppan, D. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.01.009 · Cited by 124

Ceramide-mediated biology. Determination of structural and stereospecific requirements through the use of N-acyl-phenylaminoalcohol analogs.

Bielawska, A. E., Linardic, C. M., & Hannun, Y. A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36989-3 · Cited by 123

Hedgehog regulates yes‐associated protein 1 in regenerating mouse liver

Swiderska‐Syn, M., Xie, G., Michelotti, G. A., Jewell, M. L., Premont, R. T., Syn, W., & Diehl, A. M. (2016) · Hepatology · doi:10.1002/hep.28542 · Cited by 121

Tumor suppressor Nf2 limits expansion of the neural progenitor pool by inhibiting Yap/Taz transcriptional coactivators

Lavado, A., He, Y. Y., Paré, J., Neale, G. A. M., Olson, E. N., Giovannini, M., & Cao, X. (2013) · Development · doi:10.1242/dev.096537 · Cited by 114

TAZ contributes to pulmonary fibrosis by activating profibrotic functions of lung fibroblasts

Noguchi, S. F., Saito, A., Mikami, Y., Urushiyama, H., Horie, M., Matsuzaki, H., Takeshima, H., Makita, K., Miyashita, N., Mitani, A., et al. (2017) · Scientific Reports · doi:10.1038/srep42595 · Cited by 109

Regulation of organ size: Insights from the Drosophila Hippo signaling pathway

Kango‐Singh, M., & Singh, A. (2009) · Developmental Dynamics · doi:10.1002/dvdy.21996 · Cited by 107

In vitro reversion of activated primary human hepatic stellate cells

Taghdouini, A. E., Najimi, M., Sancho‐Bru, P., Sokal, E. M., & van Grunsven, L. A. (2015) · Fibrogenesis & Tissue Repair · doi:10.1186/s13069-015-0031-z · Cited by 92

Coordinated induction of drug transporters and phase I and II metabolism in human liver slices

Olinga, P., Elferink, M. G. L., Draaisma, A. L., Merema, M. T., Castell, J. V., Pérez, G., & Groothuis, G. M. M. (2008) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2008.01.008 · Cited by 90

TAZ regulates cell proliferation and epithelial–mesenchymal transition of human hepatocellular carcinoma

Xiao, H., Jiang, N., Zhou, B., Liu, Q., & Du, C. (2014) · Cancer Science · doi:10.1111/cas.12587 · Cited by 85

Deregulation of Hippo–TAZ pathway during renal injury confers a fibrotic maladaptive phenotype

Anorga, S., Overstreet, J. M., Falke, L. L., Tang, J., Goldschmeding, R., Higgins, P. J., & Samarakoon, R. (2018) · The FASEB Journal · doi:10.1096/fj.201700722r · Cited by 85

Hippo Signaling in the Liver – A Long and Ever-Expanding Story

Manmadhan, S., & Ehmer, U. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00033 · Cited by 80

Involvement of the Hippo pathway in regeneration and fibrogenesis after ischaemic acute kidney injury: YAP is the key effector

Xu, J., Li, P.-X., Wu, J., Gao, Y., Yin, M.-X., Lin, Y., Yang, M., Chen, D., Sun, H., Liu, Z.-B., et al. (2015) · Clinical Science · doi:10.1042/cs20150385 · Cited by 79

TAZ activation drives fibroblast spheroid growth, expression of profibrotic paracrine signals, and context-dependent ECM gene expression

Jorgenson, A. J., Choi, K. M., Sicard, D., Smith, K. M. J., Hiemer, S. E., Varelas, X., & Tschumperlin, D. J. (2016) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00205.2016 · Cited by 79

The Hippo-Salvador signaling pathway regulates renal tubulointerstitial fibrosis

Seo, E., Kim, W., Hur, J., Kim, H., Nam, S. A., Choi, A., Kim, Y., Park, S. H., Chung, C., Kim, J., et al. (2016) · Scientific Reports · doi:10.1038/srep31931 · Cited by 77

Discovery and Evaluation of Inhibitors of Human Ceramidase

Draper, J. M., Xia, Z., Smith, R. A., Zhuang, Y., Wang, W., & Smith, C. D. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0365 · Cited by 75

TAZ Protein Accumulation Is Negatively Regulated by YAP Abundance in Mammalian Cells

Finch‐Edmondson, M., Strauss, R. P., Passman, A. M., Sudol, M., Yeoh, G. C., & Callus, B. A. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.692285 · Cited by 74

Novel analogs of d-e-MAPP and B13. Part 2: Signature effects on bioactive sphingolipids

Bielawska, A. E., Bielawski, J., Szulc, Z. M., Mayroo, N., Liu, X., Bai, A., Elojeimy, S. N., Rembiesa, B. M., Pierce, J. S., Norris, J. S., et al. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.08.032 · Cited by 69

A YAP/TAZ-miR-130/301 molecular circuit exerts systems-level control of fibrosis in a network of human diseases and physiologic conditions

Bertero, T., Cottrill, K. A., Annis, S., Bhat, B., Gochuico, B. R., Osorio, J. C., Rosas, I. O., Haley, K. J., Corey, K. E., Chung, R. T., et al. (2015) · Scientific Reports · doi:10.1038/srep18277 · Cited by 67

Essential roles of sphingosine 1‐phosphate receptor types 1 and 3 in human hepatic stellate cells motility and activation

Liu, X., Yue, S., Li, C., Yang, L., You, H., & Li, L. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22572 · Cited by 66

ω-3 PUFAs ameliorate liver fibrosis and inhibit hepatic stellate cells proliferation and activation by promoting YAP/TAZ degradation

Zhang, K., Chang, Y., Shi, Z., Han, X., Han, Y., Yao, Q., Hu, Z., Cui, H., Zheng, L., Han, T., et al. (2016) · Scientific Reports · doi:10.1038/srep30029 · Cited by 61

Induction of Endocytic Vesicles by Exogenous C6-ceramide

Li, R., Blanchette‐Mackie, E. J., & Ladisch, S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.30.21121 · Cited by 59

The adipokine/ceramide axis: Key aspects of insulin sensitization

Xia, J. Y., Morley, T. S., & Scherer, P. E. (2013) · Biochimie · doi:10.1016/j.biochi.2013.08.013 · Cited by 52

Liver slices as a model to study fibrogenesis and test the effects of anti-fibrotic drugs on fibrogenic cells in human liver

van de Bovenkamp, M., Groothuis, G. M. M., Meijer, D. K. F., & Olinga, P. (2008) · Toxicology in Vitro · doi:10.1016/j.tiv.2007.11.019 · Cited by 48

Construction of Conditional Acid Ceramidase Knockout Mice andin vivoEffects on Oocyte Development and Fertility

Eliyahu, E., Shtraizent, N., Shalgi, R., & Schuchman, E. H. (2012) · Cellular Physiology and Biochemistry · doi:10.1159/000341453 · Cited by 46

Biological activities of novel lipid mediator sphingosine 1-phosphate in rat hepatic stellate cells

Ikeda, H., Yatomi, Y., Yanase, M., Satoh, H., Maekawa, H., Ogata, I., Ozaki, Y., Takuwa, Y., Mochida, S., & Fujiwara, K. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.279.2.g304 · Cited by 44

Increase of Ceramide in the Liver and Plasma after Carbon Tetrachloride Intoxication in the Rat

Ichi, I., Nakahara, K., Fujii, K., Iida, C., Miyashita, Y., & Kojo, S. (2007) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.53.53 · Cited by 32

Targeting (cellular) lysosomal acid ceramidase by B13: Design, synthesis and evaluation of novel DMG-B13 ester prodrugs

Bai, A., Szulc, Z. M., Bielawski, J., Pierce, J. S., Rembiesa, B. M., Terzieva, S. I., Mao, C., Xu, R., Wu, B. X., Clarke, C. J., et al. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.10.025 · Cited by 31

Tricyclic Antidepressants Promote Ceramide Accumulation to Regulate Collagen Production in Human Hepatic Stellate Cells

Chen, J. Y., Newcomb, B., Zhou, C., Pondick, J. V., Ghoshal, S., York, S. R., Motola, D., Coant, N., Yi, J. K., Mao, C., et al. (2017) · Scientific Reports · doi:10.1038/srep44867 · Cited by 28

Functions of neutral ceramidase in the Golgi apparatus

Sakamoto, W., Coant, N., Canals, D., Obeid, L. M., & Hannun, Y. A. (2018) · Journal of Lipid Research · doi:10.1194/jlr.m088187 · Cited by 23

MASLD: a systemic metabolic disorder with cardiovascular and malignant complications

Targher, G., Byrne, C. D., & Tilg, H. (2024) · Gut · doi:10.1136/gutjnl-2023-330595 · Cited by 1,082

Preventing Engrailed-1 activation in fibroblasts yields wound regeneration without scarring

Mascharak, S., desJardins-Park, H. E., Davitt, M. F., Griffin, M., Borrelli, M. R., Moore, A. L., Chen, K., Duoto, B. A., Chinta, M. S., Foster, D. S., et al. (2021) · Science · doi:10.1126/science.aba2374 · Cited by 630

Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity

Tilg, H., Adolph, T. E., Dudek, M., & Knolle, P. A. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00501-9 · Cited by 539

Mechanoregulation of YAP and TAZ in Cellular Homeostasis and Disease Progression

Cai, X., Wang, K.-C., & Meng, Z. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.673599 · Cited by 333

Hippo signalling in the liver: role in development, regeneration and disease

Russell, J. O., & Camargo, F. D. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00571-w · Cited by 211

Tricyclic Antidepressants Promote Ceramide Accumulation to Regulate Collagen Production in Human Hepatic Stellate Cells

Chen, J. Y., Newcomb, B., Zhou, C., Pondick, J. V., Ghoshal, S., York, S. R., Motola, D., Coant, N., Yi, J. K., Mao, C., et al. (2017) · Scientific Reports · doi:10.1038/srep44867 · Cited by 28

Targeting acid ceramidase ameliorates fibrosis in mouse models of non-alcoholic steatohepatitis

Yu, A., Cable, C., Shihan, M. H., Sharma, S., Mattis, A. N., Mileva, I., Hannun, Y. A., Duwaerts, C. C., & Chen, J. Y. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.881848 · Cited by 8

AMPK stimulation inhibits YAP/TAZ signaling to ameliorate hepatic fibrosis

Shihan, M. H., Sharma, S. K., Cable, C., Prathigudupu, V., Chen, A. J., Mattis, A. N., & Chen, J. Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-55764-5 · Cited by 18

Resolving fibrosis by stimulating HSC-dependent extracellular matrix degradation

Sharma, S. K., Prathigudupu, V., Cable, C., Serrano, L. R., Nerella, S., Chen, A., Hassan, G., Lakins, J. N., Lizama, C. O., Tsukui, T., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.ads9470 · Cited by 23

Inhibition of acidic sphingomyelinase reduces established hepatic fibrosis in mice

Quillin, R. C., Wilson, G. C., Nojima, H., Freeman, C. M., Wang, J., Schuster, R. M., Blanchard, J. A., Edwards, M. J., Gandhi, C. R., Gulbins, E., et al. (2014) · Hepatology Research · doi:10.1111/hepr.12352 · Cited by 25